Nexalin Technology (NXL) Equity Average (2021 - 2026)

Nexalin Technology's Equity Average history runs 6 years deep, the most recent figure standing at $3.3 million for Q1 2026.

• In Q1 2026, Equity Average rose 10.54% year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $3.3 million (up 10.54% YoY), while the FY2025 annual figure was $3.7 million, up 7.87% from the prior year.
• Equity Average was $3.3 million for Q1 2026 at Nexalin Technology, down from $4.3 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $5.9 million in Q4 2022 to a low of -$2.1 million in Q2 2022.
• Historically, Equity Average has averaged $3.1 million across 5 years, with a median of $3.3 million in 2026.
• The sharpest annual moves came in 2022 and 2024: Equity Average surged 424.18% in 2022, then sank 57.86% in 2024.
• A 5-year view of Equity Average shows it stood at $5.9 million in 2022, then tumbled by 45.55% to $3.2 million in 2023, then soared by 34.0% to $4.3 million in 2024, then declined by 1.36% to $4.3 million in 2025, then retreated by 22.1% to $3.3 million in 2026.
• The last three Equity Average figures came in at $3.3 million (Q1 2026), $4.3 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.